MedTrace Logo

Nasal Swab Study to Explore the Nasal Microbia

NCT02535442 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2016-07-04

No results posted yet for this study

Summary

The objective of this study is to evaluate the microbial consortia and the host inflammatory factors present in the nasal passages of patients during upper respiratory symptomology and when healthy using culture and molecular analysis techniques.

Conditions

  • Common Cold

Sponsors & Collaborators

  • Kimberly-Clark Corporation

    lead INDUSTRY

Principal Investigators

  • Charles Fogarty, MD · Spartanburg Medical Research

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-04-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02535442 on ClinicalTrials.gov